Back to Search Start Over

Deep sequencing analysis of clinical samples from patients with acute infectious conjunctivitis during the COVID-19 delta surge in Madurai, India.

Authors :
Lalitha, Prajna
Prajna, N Venkatesh
Gunasekaran, Rameshkumar
Teja, Gonugunta Vishnu
Sharma, Sankalp S.
Hinterwirth, Armin
Ruder, Kevin
Zhong, Lina
Chen, Cindi
Deiner, Michael
Huang, ChunHong
Pinsky, Benjamin A.
Lietman, Thomas M.
Doan, Thuy
Seitzman, Gerami D.
Source :
Journal of Clinical Virology. Dec2022, Vol. 157, pN.PAG-N.PAG. 1p.
Publication Year :
2022

Abstract

• During the COVID-19 delta surge in southern India, human adenoviruses remain the predominant pathogens causing outpatient conjunctivitis (pink eye). • SARS-CoV-2 was associated with 11% of all cases. • Broad pathogen testing for acute conjunctivitis may be useful from a public health surveillance standpoint as it allows for the detection of unanticipated pathogens and unexpected co-infections. Seasonal outbreaks of infectious conjunctivitis remain a public health issue. Determination of outbreak etiologies in the context of a worldwide pandemic may provide useful information to guide public health strategies. The aim of this study was to identify pathogens associated with outpatient infectious conjunctivitis during the COVID-19 Delta surge. This prospective study was conducted from April 2021 to September 2021. All outpatients presenting to the Aravind Eye Center (Madurai, India) with signs and symptoms consistent with acute infectious conjunctivitis were eligible. Three swabs were obtained from each participant: one from each conjunctiva and one from the anterior nares. Samples were processed for metagenomic RNA deep sequencing (RNA-seq). Samples from 106 study participants were sequenced. The most common presenting symptoms were tearing (86%) and itching (71%). Preauricular lymphadenopathy was present in 38% of participants. 20% of participants had close contacts with similar symptoms. Systemic symptoms such as coughing, runny nose, vomiting or diarrhea were uncommonly reported. 60% of all participants used some medicated eye drops upon enrollment. 75% of study participants demonstrated infection with human adenovirus D (HAdV-D). 11% of conjunctivitis was associated with SARS-CoV-2. 15% had no definitive pathogen detected. 8% of all participants had codetection of more than one pathogen on RNA-seq. During the COVID-19 Delta surge in India, HAdV-D was the most common pathogen associated with infectious conjunctivitis. SARS-CoV-2 was the second most common associated pathogen. Seasonal surveillance may be necessary for the determination of emerging and reemerging pathogens responsible for infectious conjunctivitis. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13866532
Volume :
157
Database :
Academic Search Index
Journal :
Journal of Clinical Virology
Publication Type :
Academic Journal
Accession number :
160335979
Full Text :
https://doi.org/10.1016/j.jcv.2022.105318